Stablepharma Ltd Press Releases - EIN Presswire - Press Release Distribution Service

Published on October 15, 2026 - 13:30 GMT

TIME Names Stablepharma's Fridge-Free Vaccine a Best Invention of 2026

SPVX02 recognised in TIME's Medical & Healthcare category as Stablepharma enters its temperature-stable tetanus-diphtheria vaccine into a pivotal Phase 2b trial LONDON, ENG, UNITED KINGDOM, October 15, 2026 /⁨EINPresswire.com⁩/ -- Stablepharma Ltd …

Distribution channels: Environment, Healthcare & Pharmaceuticals Industry ...

Published on October 7, 2026 - 04:00 GMT

Stablepharma Doses First Patient in Pivotal Phase 2b Trial After Positive Clinical Results

The pivotal 160-patient study represents the final clinical step towards commercialisation of SPVX02, Stablepharma's fridge-free, freeze-resistant Td vaccine. LONDON, ENG, UNITED KINGDOM, October 7, 2026 /⁨EINPresswire.com⁩/ -- Following publication …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on August 5, 2026 - 22:30 GMT

The Lancet’s eClinicalMedicine Publishes Phase I Data for SPVX02, a Fridge-free Td Vaccine Stable for 24 Months at 30°C

Stablepharma announce Phase 1 clinical trial results for SPVX02, a thermostable reformulation of a licensed Td vaccine, published in the eClinicalMedicine LONDON, ENG, UNITED KINGDOM, August 5, 2026 /⁨EINPresswire.com⁩/ -- Stablepharma Limited today …

Distribution channels: Environment, Healthcare & Pharmaceuticals Industry ...

Published on June 15, 2026 - 05:00 GMT

Stablepharma and AFT Move to Expand Fridge-Free Vaccine Distribution Following Positive Clinical Data

Stablepharma, specialists in thermostable formulations, signed LOI with AFT for distribution of SPVX02, a fridge-free Td vaccine, in UK, Canada, Australia & NZ LONDON, UNITED KINGDOM, June 15, 2026 /⁨EINPresswire.com⁩/ -- Potential agreement follows …

Distribution channels: Banking, Finance & Investment Industry, Environment ...